Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
MP-1032 by MetrioPharm for Coronavirus Disease 2019 (COVID-19): Likelihood of Approval
MP-1032 is under clinical development by MetrioPharm and currently in Phase II for Coronavirus Disease 2019 (COVID-19). According to GlobalData,...
MP-1032 by MetrioPharm for Inflammatory Bowel Disease: Likelihood of Approval
MP-1032 is under clinical development by MetrioPharm and currently in Phase I for Inflammatory Bowel Disease. According to GlobalData, Phase...
MP-1032 by MetrioPharm for Multiple Sclerosis: Likelihood of Approval
MP-1032 is under clinical development by MetrioPharm and currently in Phase I for Multiple Sclerosis. According to GlobalData, Phase I...
MP-1032 by MetrioPharm for Unspecified Infectious Diseases: Likelihood of Approval
MP-1032 is under clinical development by MetrioPharm and currently in Phase I for Unspecified Infectious Diseases. According to GlobalData, Phase...